14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $26.98 $26.98 Thursday, 8th Jun 2023 MYOV stock ended at $26.98. During the day the stock fluctuated 0% from a day low at $26.98 to a day high of $26.98.
90 days $26.98 $26.98
52 weeks $9.81 $27.06

Historical Myovant Sciences Ltd prices

Date Open High Low Close Volume
Jan 13, 2023 $26.95 $26.95 $26.85 $26.90 2 385 007
Jan 12, 2023 $26.94 $26.97 $26.90 $26.97 2 183 100
Jan 11, 2023 $26.92 $26.96 $26.92 $26.93 2 020 655
Jan 10, 2023 $26.93 $26.96 $26.92 $26.94 1 814 500
Jan 09, 2023 $26.96 $26.98 $26.91 $26.91 1 998 000
Jan 06, 2023 $26.89 $26.96 $26.88 $26.90 1 698 500
Jan 05, 2023 $26.91 $26.92 $26.88 $26.89 2 650 442
Jan 04, 2023 $26.90 $26.97 $26.87 $26.87 732 737
Jan 03, 2023 $26.94 $27.02 $26.87 $26.93 1 338 000
Dec 30, 2022 $26.96 $26.96 $26.91 $26.96 302 089
Dec 29, 2022 $26.95 $26.98 $26.91 $26.97 682 936
Dec 28, 2022 $26.91 $26.96 $26.87 $26.94 590 300
Dec 27, 2022 $26.93 $26.95 $26.85 $26.90 612 954
Dec 23, 2022 $26.97 $26.98 $26.93 $26.94 292 177
Dec 22, 2022 $26.89 $27.03 $26.89 $27.02 708 561
Dec 21, 2022 $26.84 $27.02 $26.84 $27.01 669 624
Dec 20, 2022 $26.83 $26.91 $26.81 $26.89 567 444
Dec 19, 2022 $26.85 $26.87 $26.82 $26.84 339 082
Dec 16, 2022 $26.75 $26.97 $26.75 $26.89 1 798 670
Dec 15, 2022 $26.89 $26.89 $26.80 $26.80 966 184
Dec 14, 2022 $26.87 $26.90 $26.86 $26.89 517 532
Dec 13, 2022 $26.85 $26.92 $26.82 $26.92 433 841
Dec 12, 2022 $26.85 $26.87 $26.80 $26.87 544 398
Dec 09, 2022 $26.84 $26.85 $26.79 $26.79 371 879
Dec 08, 2022 $26.88 $26.88 $26.84 $26.84 155 299
Click to get the best stock tips daily for free!

About Myovant Sciences Ltd

Myovant Sciences Ltd Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, whic... MYOV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT